Rotator cuff tendinopathy. Impingement syndrome of shoulder
Conditions
Interventions
Intervention 1: Control group: In this group, the drug treatment will be one tablet of meloxicam 15 mg with food once a day for two weeks and exercise therapy three times a week for three weeks. Inter
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with unilateral rotator cuff tendinopathy Signature of consent form Have previous normal radiography of the shoulder
Exclusion criteria
Exclusion criteria: previous surgery of the injured shoulder luxation or fracture near the shoulder Direct or indirect severe injuries following traction Coagulation disorders neurological injuries or illnesses with musculoskeletal disorders Vascular disorders in the lower extremities lymphedema Kidney disease (creatinine greater than 1.5) ?Drug consumption History of cancer Inability to communicate and cognitive impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before, immediately and three months after the intervention. Method of measurement: with Visual analogue scale (VAS).;Shoulder joint function. Timepoint: Before, immediately and three months after the intervention. Method of measurement: Disabilities of the Arm, Shoulder, and Hand outcome Measure (DASH).;Painful range of shoulder joint. Timepoint: Before, immediately and three months after the intervention. Method of measurement: with Goniometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaranak Seydi
Esfahan University of Medical Sciences
Outcome results
None listed